Haymaker Acquisition Corp Valuation
BTMDWDelisted Stock | USD 1.61 0.05 3.21% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Haymaker Acquisition Corp retains a regular Real Value of $1.1 per share. The prevalent price of the firm is $1.61. Our model calculates the value of Haymaker Acquisition Corp from evaluating the firm fundamentals such as Profit Margin of 0.85 %, price to earning of 0.01 X, and Return On Asset of 0.5 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Haymaker Acquisition's price fluctuation is very steady at this time. Calculation of the real value of Haymaker Acquisition Corp is based on 3 months time horizon. Increasing Haymaker Acquisition's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Haymaker stock is determined by what a typical buyer is willing to pay for full or partial control of Haymaker Acquisition Corp. Since Haymaker Acquisition is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Haymaker Stock. However, Haymaker Acquisition's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.61 | Real 1.1 | Hype 1.61 |
The intrinsic value of Haymaker Acquisition's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Haymaker Acquisition's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Haymaker Acquisition Corp helps investors to forecast how Haymaker stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Haymaker Acquisition more accurately as focusing exclusively on Haymaker Acquisition's fundamentals will not take into account other important factors: Haymaker Acquisition Total Value Analysis
Haymaker Acquisition Corp is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of 120.43 M, and cash on hands of 27.7 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Haymaker Acquisition fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 120.43 M | 27.7 M |
Haymaker Acquisition Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Haymaker Acquisition has an asset utilization ratio of 147.75 percent. This indicates that the Company is making $1.48 for each dollar of assets. An increasing asset utilization means that Haymaker Acquisition Corp is more efficient with each dollar of assets it utilizes for everyday operations.Haymaker Acquisition Profitability Analysis
The company reported the revenue of 164.96 M. Net Income was 1.32 M with profit before overhead, payroll, taxes, and interest of 0.About Haymaker Acquisition Valuation
Our relative valuation model uses a comparative analysis of Haymaker Acquisition. We calculate exposure to Haymaker Acquisition's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Haymaker Acquisition's related companies.biote Corp. operates in medical practice-building business within the hormone optimization space. The company was founded in 2011 and is headquartered in Irvine, Texas. Biote Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange.
Haymaker Acquisition Growth Indicators
Investing in growth stocks can be very risky. If the company such as Haymaker Acquisition does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 8.1 B | |
Quarterly Earnings Growth Y O Y | 0.058 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Haymaker Stock
If you are still planning to invest in Haymaker Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Haymaker Acquisition's history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |